These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9769951)

  • 1. TP53 and oesophageal cancer.
    Ferec C; Giroux MA; Audrezet MP; Robaszkiewicz M
    Pathol Biol (Paris); 1997 Dec; 45(10):871-5. PubMed ID: 9769951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene activation in esophageal cancer.
    Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):707-9. PubMed ID: 1943188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 gene mutation profile in esophageal squamous cell carcinomas.
    Audrézet MP; Robaszkiewicz M; Mercier B; Nousbaum JB; Bail JP; Hardy E; Volant A; Lozac'h P; Charles JF; Gouéron H
    Cancer Res; 1993 Dec; 53(23):5745-9. PubMed ID: 8242631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report.
    Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
    Hepatogastroenterology; 2001; 48(42):1662-4. PubMed ID: 11813596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-mutant clones and field effects in Barrett's esophagus.
    Prevo LJ; Sanchez CA; Galipeau PC; Reid BJ
    Cancer Res; 1999 Oct; 59(19):4784-7. PubMed ID: 10519384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
    Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
    Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
    Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
    Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
    Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
    Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
    Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
    Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
    Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
    Chung SM; Kao J; Hyjek E; Chen YT
    Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ
    Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and neoplastic progression in Barrett's esophagus.
    Reid BJ
    Am J Gastroenterol; 2001 May; 96(5):1321-3. PubMed ID: 11374661
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
    Paget V; Lechevrel M; Sichel F
    Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.